Related Experiment Video
Updated: Jan 16, 2026

09:38
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.4K
Critical Considerations for the Evaluation of Lazertinib in NSCLC With Uncommon EGFR Mutations
1School of Laboratory Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Abstract
No abstract available in PubMed .
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
9.2K